Skip to content

Prof Marinko visit the AOG! – April 2022

The last Thursday 21st April 2022, Prof Marinko visited the AOG and gave a talk about his recent developments in the OCT field with a special interest in how to take advantage of AI with OCT-A. Check below the abstract of the talk.

Visit Prof. Marinko, photo in Ingram. From left to right: Rasmus Eilkaer, Julien Camard (VP Optica Chapter), Rene Riha, Adrian Fernandez (Member Optica Chapter), Dr George Dobre, Alejandro Martinez (P Optica Chapter), Prof Adrian Podoleanu, Esteban Proano, Prof Marinko, Dr Manuel Marques, Irene Rodriguez, Giannis Nteroli (Member Optica Chapter), Gopika Venugopal (Member Optica Chapter), Dr Adrian Bradu

Title: OCT Angiography and AI for Diabetic Retinopathy

Abstract: Diabetic Retinopathy (DR) is one of the leading causes of
vision loss in working age adults. The pathological changes to the
retina, the light sensitive tissue at the back of the eye, due to DR can
be imaged with optical coherence tomography (OCT), and the
microvasculature visualized with OCT Angiography (OCTA). Artificial
intelligence (AI) tools to analyse the OCT intensity and OCTA flow
contrast image data may assist with the classification of DR, and has
potential to identify early changes that may be predictive of disease

Bio: Prof Marinko Sarunic's research investigates optical imaging
devices for biomedical applications. Prof. Sarunic completed
undergraduate studies at Simon Fraser University (Vancouver, BC, Canada)
and a doctoral degree at Duke University (Durham, NC, USA). The main
research focus is on optical coherence tomography (OCT), a non-invasive,
three-dimensional, micrometer-resolution imaging technique using the
interference of light. Prof. Sarunic's group designs and constructs OCT
imaging systems primarily for studies in ophthalmology and vision
science. In addition to OCT, their work covers various techniques for
structural and functional optical imaging and analysis.

Leave a Reply

Your email address will not be published. Required fields are marked *